2Mathieu P,Despres JP,Pibarot P.The valvulo-metabolic risk in calcific aortic valve disease[].Canadian Journal of Cardiology.2007
3Minamino T,Kitakaze M,Sato H,Asanuma H,Funaya H,Koretsune Y,Hori M.Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation[].Arteriosclerosis and Thrombosis.1997
5Parolari A,Loardi C,Mussoni L,Cavallotti L,Camera M,Biglioli P,Tremoli E,Alamanni F.Nonrheumatic calcific aortic stenosis:an overview from basic science to pharmacological prevention[].European Journal of Cardio Thoracic Surgery.2009
6LM Moura,SF Ramos,JL Zamorano,IM Barros,LF Azevedo,F Rocha-Goncalves,NM Rajamannan.Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis[].Journal of the American College of Cardiology.2007
7Helske S,Syvaranta S,Kupari M,et al.Possible role for mast cell-derived cathepsin G in the adverse remodeling of stenosis aortic values[].European Heart Journal.2006
8Katz R,Wong ND,Kronmal R,et al.Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calci-fication in the multi-ethnic study of atherosclerosis[].Circulation.2006
9Arishiro K,Hoshiga M,Negoro N, et al.Angiotensin receptor1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits[].Journal of the American College of Cardiology.2007
10Yetkin E,Waltenberger J.Molecular and cellular mechanisms of aortic stenosis[].International Journal of Cardiology.2009
3Horstkotte D, Piper C. Management of patients with heart valve diseases in 2008. What has changed in the last three decades? Dtsch Med Wochenschr, 2008, i33(Suppl 8):S280-284.
4Shi JH, Meng X, Han J, et al. A mortality risk assessment model for cardiac valve replacement surgery and its application in the use of prophylactic extracorporeal membrane oxygenation. Int J Surg, 2010, 95(3): 227-231.
5Aikawa E, Aikawa M, Libby P, et al. Arterial and aortic valve calci- fication abolished by elastolytic cathepsin S deficiency in chronic renal disease [J]. Circulation, 2009, 119 (13): 1785-1794.
6Yetkin E, Waltenberger J. Molecularand cellular mechanisms of aortic stenosis [J]. Int ] Cardiol, 2009, 135 (l) : 4-13.
7Weiss RM, Ohashi M, Miller JD, et al. Calcific aortic valve stenosis in old hypercholesterolemie mice ~ J]. Circulation, 2006, 114 (19) : 2065 - 2069.
8Pamlafi A, Loardi C, Mussoni L, et al. Nonrheunmatic calcific aortic stenosis: an overview from basic science to pharmacological prevention [J]. Eur J Cardiothorac Surg, 2009, 35 (3) : 493 -504.
9Mathieu P, Despres JP, Pibarot P. The'valvulo - metabolic'risk in cal- cific aortic valve disease [J]. Can J Cardiol, 2007, 23 (Suppl B): 32B -39B.
10NesticoP, Depace N, Morganroth J. Mitral annular calcification:clinical, pathophysiological and echocardiographic review[J]. Heart,1984,107(1): 989-996.
